PNC Financial Services Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,314
| Closed | -$107K | – | 4364 |
|
|
2021
Q1 | $107K | Sell |
1,314
-81
| -6% | -$6.33K | ﹤0.01% | 2541 |
|
|
2020
Q4 | $108K | Sell |
1,395
-708
| -34% | -$41.5K | ﹤0.01% | 2441 |
|
|
2020
Q3 | $93K | Sell |
2,103
-67
| -3% | -$3.3K | ﹤0.01% | 2364 |
|
|
2020
Q2 | $96K | Sell |
2,170
-1,659
| -43% | -$61.9K | ﹤0.01% | 2361 |
|
|
2020
Q1 | $137K | Sell |
3,829
-2,050
| -35% | -$117K | ﹤0.01% | 2033 |
|
|
2019
Q4 | $416K | Buy |
5,879
+1,928
| +49% | +$140K | ﹤0.01% | 1582 |
|
|
2019
Q3 | $295K | Buy |
3,951
+11
| +0.3% | +$932 | ﹤0.01% | 1903 |
|
|
2019
Q2 | $319K | Sell |
3,940
-17,792
| -82% | -$1.25M | ﹤0.01% | 1891 |
|
|
2019
Q1 | $1.46M | Sell |
21,732
-68,269
| -76% | -$5.17M | ﹤0.01% | 1141 |
|
|
2018
Q4 | $6.7M | Sell |
90,001
-8,559
| -9% | -$707K | 0.01% | 591 |
|
|
2018
Q3 | $9.07M | Sell |
98,560
-16,313
| -14% | -$1.55M | 0.01% | 569 |
|
|
2018
Q2 | $11.3M | Sell |
114,873
-6,412
| -5% | -$717K | 0.01% | 511 |
|
|
2018
Q1 | $13.5M | Sell |
121,285
-1,447
| -1% | -$162K | 0.01% | 466 |
|
|
2017
Q4 | $12.6M | Sell |
122,732
-9,027
| -7% | -$899K | 0.01% | 484 |
|
|
2017
Q3 | $12.4M | Buy |
131,759
+8,622
| +7% | +$681K | 0.01% | 475 |
|
|
2017
Q2 | $9.59M | Buy |
123,137
+754
| +0.6% | +$56.6K | 0.01% | 522 |
|
|
2017
Q1 | $9.8M | Buy |
122,383
+7,785
| +7% | +$619K | 0.01% | 507 |
|
|
2016
Q4 | $9.03M | Buy |
114,598
+4,872
| +4% | +$379K | 0.01% | 514 |
|
|
2016
Q3 | $8.56M | Buy |
109,726
+6,434
| +6% | +$467K | 0.01% | 529 |
|
|
2016
Q2 | $7.1M | Buy |
103,292
+8,198
| +9% | +$565K | 0.01% | 558 |
|
|
2016
Q1 | $6.79M | Buy |
95,094
+18,582
| +24% | +$1.17M | 0.01% | 571 |
|
|
2015
Q4 | $4.75M | Buy |
76,512
+7,459
| +11% | +$455K | 0.01% | 632 |
|
|
2015
Q3 | $3.92M | Buy |
69,053
+4,970
| +8% | +$263K | ﹤0.01% | 700 |
|
|
2015
Q2 | $3.44M | Buy |
64,083
+12,902
| +25% | +$628K | ﹤0.01% | 773 |
|
|
2015
Q1 | $2.43M | Buy |
51,181
+9,755
| +24% | +$432K | ﹤0.01% | 870 |
|
|
2014
Q4 | $1.79M | Buy |
41,426
+5,093
| +14% | +$208K | ﹤0.01% | 965 |
|
|
2014
Q3 | $1.25M | Buy |
36,333
+1,211
| +3% | +$42.8K | ﹤0.01% | 1043 |
|
|
2014
Q2 | $1.29M | Buy |
35,122
+151
| +0.4% | +$5.12K | ﹤0.01% | 1006 |
|
|
2014
Q1 | $1.18M | Buy |
34,971
+587
| +2% | +$19.4K | ﹤0.01% | 1010 |
|
|
2013
Q4 | $1.17M | Sell |
34,384
-2,942
| -8% | -$102K | ﹤0.01% | 981 |
|
|
2013
Q3 | $1.19M | Buy |
37,326
+1,561
| +4% | +$41.5K | ﹤0.01% | 954 |
|
|
2013
Q2 | $808K | Buy |
+35,765
| New | +$774K | ﹤0.01% | 1063 |
|
PNC Financial Services Group's CMD Position: Q2 2021 in Review
PNC Financial Services Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,314 shares — an estimated $107K sold.
PNC Financial Services Group first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $13.5M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- PNC Financial Services Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- PNC Financial Services Group sold 1,314 Cantel Medical Corporation shares in Q2 2021, an estimated $107K.
- PNC Financial Services Group first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- PNC Financial Services Group's Cantel Medical Corporation position peaked at $13.5M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on PNC Financial Services Group's 13F filing for Q2 2021, filed 6 Aug 2021.